BSE Live
Feb 13, 09:27Prev. Close
1003.75
Open Price
993.05
Bid Price (Qty.)
998.00 (1)
Offer Price (Qty.)
1000.55 (8)
NSE Live
Feb 13, 09:27Prev. Close
1002.30
Open Price
1001.00
Bid Price (Qty.)
999.50 (42)
Offer Price (Qty.)
999.60 (1)
| Cash Flow of Epigral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 540.10 | 290.67 | 522.53 | 383.42 | 160.86 | |
| Net CashFlow From Operating Activities | 440.56 | 397.69 | 626.16 | 283.82 | 229.22 | |
| Net Cash Used In Investing Activities | -261.56 | -401.10 | -437.22 | -454.68 | -196.73 | |
| Net Cash Used From Financing Activities | -163.54 | -7.60 | -199.79 | 195.22 | -31.90 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 15.46 | -11.01 | -10.85 | 24.36 | 0.58 | |
| Cash And Cash Equivalents Begin of Year | 3.18 | 14.19 | 25.04 | 0.68 | 0.10 | |
| Cash And Cash Equivalents End Of Year | 18.64 | 3.18 | 14.19 | 25.04 | 0.68 |
03.02.2026
Epigral Consolidated December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
03.02.2026
Epigral Standalone December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
30.01.2026
Astral, Epigral to gain from China’s VAT rebate rollback on PVC
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
03.02.2026
Epigral Consolidated December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
03.02.2026
Epigral Standalone December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
11.11.2025
Epigral Standalone September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y